Investment
Features
FeesSafety
Academy
More
Pluang+

Compare YieldMax AI & Tech Portfolio Option Income ETF (GPTY) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance

YieldMax AI & Tech Portfolio Option Income ETFTrade
ImmunityBio Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

YieldMax AI & Tech Portfolio Option Income ETF vs ImmunityBio Inc. Common Stock — how do they compare? YieldMax AI & Tech Portfolio Option Income ETF trades at $42.75 (market cap $135.69M), while ImmunityBio Inc. Common Stock trades at $10.03 (market cap $10.51B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 77.5× YieldMax AI & Tech Portfolio Option Income ETF's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, YieldMax AI & Tech Portfolio Option Income ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold YieldMax AI & Tech Portfolio Option Income ETF for 60 Days and ImmunityBio Inc. Common Stock for 0 Days on average.

GPTYIBRX
Market Cap
$135.69M$10.51B
Volume
97,44210,445,785
Sector
Income / Options OverlayHealth
52-Week High
$50.52$11.55
52-Week Low
$34.73$1.98
Typical Hold Time
60 Days0 Days
Enterprise Value
—$10.97B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GPTY
100% Buy0% Sell
Avg holding period · 60 Days
IBRX
100% Buy0% Sell
Avg holding period · 0 Days

About YieldMax AI & Tech Portfolio Option Income ETF

GPTY is an actively managed ETF that seeks to provide current income and capital appreciation by holding a concentrated portfolio of 15 to 30 leading AI and technology companies. It utilizes a variety of options strategies, including selling call options on its underlying holdings, to generate weekly distributions while maintaining direct equity exposure to the growth of the AI sector.

Read more on GPTY →

About ImmunityBio Inc. Common Stock

ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.

Read more on IBRX →